Concepedia

Romy M. van Amelsfoort

RM

Statistics

Publications

6

Citations

214

H-Index

6

Active since

2014

Affiliations

The Netherlands Cancer Institute(Current)

Leiden University Medical Center

Amsterdam UMC Location Vrije Universiteit Amsterdam

Radboud University Nijmegen

Radboud University Medical Center

Romy M. van Amelsfoort is an author at The Netherlands Cancer Institute specializing in medicine, oncology, and gastrointestinal oncology.

ORCID

Publications per year

2014–2022

6

Publications

6

Adjuvant chemotherapy is superior to chemoradiation after D2 surgery for gastric cancer in the per-protocol analysis of the randomized CRITICS trial

Wobbe O. de Steur, Romy M. van Amelsfoort, H.H. Hartgrink et al. · Annals of Oncology · 2020 · 67 citations · Full text

, , +17

Altered exhaled biomarker profiles in children during and after rhinovirus-induced wheeze

Marc P. van der Schee, Simone Hashimoto, A.C. Schuurman et al. · European Respiratory Journal · 2014 · 52 citations · Full text

, , +16

Effect of Hospital Volume With Respect to Performing Gastric Cancer Resection on Recurrence and Survival

Y.H.M. Claassen, Romy M. van Amelsfoort, Henk H. Hartgrink et al. · Annals of Surgery · 2018 · 38 citations · Full text

, , +16

Older versus younger adults with gastric cancer receiving perioperative treatment: Results from the CRITICS trial

Astrid E. Slagter, B. Tudela, Romy M. van Amelsfoort et al. · European Journal of Cancer · 2020 · 25 citations · Full text

, , +17

Quality of Life Is Associated With Survival in Patients With Gastric Cancer: Results From the Randomized CRITICS Trial

Romy M. van Amelsfoort, Iris Walraven, Jacobien M. Kieffer et al. · Journal of the National Comprehensive Cancer Network · 2022 · 19 citations · Full text

, , +13

1–5 of 6